Antibody Drug Conjugate News and Research

RSS
Experimental antibody drug shrinks tumors in soft tissue sarcoma trial

Experimental antibody drug shrinks tumors in soft tissue sarcoma trial

Investigational antibody-drug conjugate shows promise in advanced head and neck cancer

Investigational antibody-drug conjugate shows promise in advanced head and neck cancer

Mayo Clinic research advances treatment options for genitourinary cancers

Mayo Clinic research advances treatment options for genitourinary cancers

New treatment approach could help people with muscle-invasive bladder cancer live longer

New treatment approach could help people with muscle-invasive bladder cancer live longer

Dual-targeted therapy shows promise against metastatic triple-negative breast cancer

Dual-targeted therapy shows promise against metastatic triple-negative breast cancer

New mathematical model tracks how tumor environment impacts cancer therapies

New mathematical model tracks how tumor environment impacts cancer therapies

Tam-Peli significantly extends survival in relapsed small-cell lung cancer

Tam-Peli significantly extends survival in relapsed small-cell lung cancer

Ris-Rez improves survival in patients with relapsed small-cell lung cancer

Ris-Rez improves survival in patients with relapsed small-cell lung cancer

Low discontinuation rates confirm manageable safety of iza-bren

Low discontinuation rates confirm manageable safety of iza-bren

Tumor DNA clearance reaches 39% in novel immunomodulator and ADC combination

Tumor DNA clearance reaches 39% in novel immunomodulator and ADC combination

Computational pipeline uncovers subtype specific targets for cervical cancer

Computational pipeline uncovers subtype specific targets for cervical cancer

Phase 3 clinical trial enrolls first platinum-resistant ovarian cancer patient

Phase 3 clinical trial enrolls first platinum-resistant ovarian cancer patient

Self-assembling antibody drugs successfully target multiple cancer receptors

Self-assembling antibody drugs successfully target multiple cancer receptors

Novel leukemia therapy successfully eradicates measurable residual disease

Novel leukemia therapy successfully eradicates measurable residual disease

German study identifies therapeutic Achilles' heel for advanced colorectal cancer

German study identifies therapeutic Achilles' heel for advanced colorectal cancer

Review outlines key strategies to overcome antibody drug conjugate resistance

Review outlines key strategies to overcome antibody drug conjugate resistance

New human protein atlas maps how cancer rewires the body’s tissues

New human protein atlas maps how cancer rewires the body’s tissues

New spatial map reveals treatment vulnerabilities in bladder cancer

New spatial map reveals treatment vulnerabilities in bladder cancer

Polymer-based immunotherapies enhance tumor targeting and immune activation

Polymer-based immunotherapies enhance tumor targeting and immune activation

How antibody-drug conjugates are redefining targeted cancer therapy

How antibody-drug conjugates are redefining targeted cancer therapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.